NVAX--
SNY--

nvax sanofi deal edge puzzling product top tier

$NVAX Perhaps they have a deal with Sanofi that gives them an edge. If that's true, it's a bad sign. Otherwise, it's puzzling. How long can they keep a product that could be top-tier in the background? We've been waiting three years. Since the Sanofi deal, it seems like CIC got pushed aside. They barely mention it now, which only fuels investor anger and rumors. $NVAX
Community post image

Comments



No comments

No comments yet

Disclaimer: The above is a summary showing certain market information. Ainvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing, All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market.Report an Issue